Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.880
+0.160 (5.88%)
Jan 9, 2026, 9:32 AM EST - Market open
Genelux Employees
Genelux had 24 employees as of December 31, 2024. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,328,083
Market Cap
108.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24 | 1 | 4.35% |
| Dec 31, 2023 | 23 | 8 | 53.33% |
| Dec 31, 2022 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GNLX News
- 1 day ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 1 day ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 7 days ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 5 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 6 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire
- 8 months ago - Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 10 months ago - Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire